Improved pre-operative diagnostic accuracy for low-grade prosthetic joint infections using second-generation multiplex Polymerase chain reaction on joint fluid aspirate.

Agent Arthrocentesis Bacteria Bacterial Causative organism DNA Detection Diagnosis PJI Polymerase chain reaction, diagnostic Pre-operative Synovial fluid

Journal

International orthopaedics
ISSN: 1432-5195
Titre abrégé: Int Orthop
Pays: Germany
ID NLM: 7705431

Informations de publication

Date de publication:
09 2020
Historique:
received: 20 12 2019
accepted: 26 03 2020
pubmed: 17 4 2020
medline: 15 4 2021
entrez: 17 4 2020
Statut: ppublish

Résumé

A major obstacle for the treatment of prosthetic joint infection (PJI) is the identification of the underlying causative organism. While the diagnostic criteria ruling PJI in or out have become ever more accurate, the detection of the causative pathogen(s) still relies mostly on conventional and time-consuming microbial culture. The aim of this study was to evaluate the diagnostic potential of a second-generation multiplex PCR assay (Unyvero ITI G2, Curetis AG, Holzgerlingen, Germany) used on synovial fluid specimens. Our hypothesis was that the method would yield a higher diagnostic accuracy in the pre-operative workup than synovial fluid culture. Thus, a more precise classification of septic and aseptic prosthesis failure could be achieved before revision surgery. Prospectively collected frozen joint fluid specimens from 26 patients undergoing arthroplasty revision surgery of the hip or knee were tested as per the manufacturer's protocol. Sensitivities, specificities, positive and negative predictive values as well as positive and negative likelihood ratios with corresponding confidence intervals were estimated using the statistical software R. A combination of the serum C-reactive protein (CRP) level, leukocyte count, erythrocyte sedimentation rate, joint fluid culture, tissue biopsy culture, and tissue biopsy histology served as the gold standard. Of the 26 patients included in the study, 15 were infected and 11 were aseptic. Conventional joint fluid culture showed a sensitivity of 0.67 and a specificity of 0.91. Joint fluid multiplex PCR yielded a sensitivity of 0.8 and a specificity of 1.0. Using the second-generation Unyvero ITI cartridge on joint fluid aspirate for the detection of prosthetic joint infection, we were able to achieve a higher diagnostic accuracy than with conventional culture. We conclude that to improve pathogen detection before revision surgery, this method represents a valuable and practicable tool.

Sections du résumé

BACKGROUND
A major obstacle for the treatment of prosthetic joint infection (PJI) is the identification of the underlying causative organism. While the diagnostic criteria ruling PJI in or out have become ever more accurate, the detection of the causative pathogen(s) still relies mostly on conventional and time-consuming microbial culture. The aim of this study was to evaluate the diagnostic potential of a second-generation multiplex PCR assay (Unyvero ITI G2, Curetis AG, Holzgerlingen, Germany) used on synovial fluid specimens. Our hypothesis was that the method would yield a higher diagnostic accuracy in the pre-operative workup than synovial fluid culture. Thus, a more precise classification of septic and aseptic prosthesis failure could be achieved before revision surgery.
METHODS
Prospectively collected frozen joint fluid specimens from 26 patients undergoing arthroplasty revision surgery of the hip or knee were tested as per the manufacturer's protocol. Sensitivities, specificities, positive and negative predictive values as well as positive and negative likelihood ratios with corresponding confidence intervals were estimated using the statistical software R. A combination of the serum C-reactive protein (CRP) level, leukocyte count, erythrocyte sedimentation rate, joint fluid culture, tissue biopsy culture, and tissue biopsy histology served as the gold standard.
RESULTS
Of the 26 patients included in the study, 15 were infected and 11 were aseptic. Conventional joint fluid culture showed a sensitivity of 0.67 and a specificity of 0.91. Joint fluid multiplex PCR yielded a sensitivity of 0.8 and a specificity of 1.0.
CONCLUSIONS
Using the second-generation Unyvero ITI cartridge on joint fluid aspirate for the detection of prosthetic joint infection, we were able to achieve a higher diagnostic accuracy than with conventional culture. We conclude that to improve pathogen detection before revision surgery, this method represents a valuable and practicable tool.

Identifiants

pubmed: 32296908
doi: 10.1007/s00264-020-04552-7
pii: 10.1007/s00264-020-04552-7
pmc: PMC7452934
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1629-1637

Références

Am J Orthop (Belle Mead NJ). 2011 Dec;40(12):614-5
pubmed: 22268006
Eur J Clin Microbiol Infect Dis. 2017 Jan;36(1):1-9
pubmed: 27649698
J Arthroplasty. 2014 Nov;29(11):2181-6
pubmed: 25124809
Infection. 2017 Dec;45(6):877-884
pubmed: 28983865
J Arthroplasty. 2018 May;33(5):1309-1314.e2
pubmed: 29551303
J Orthop Sci. 2017 Mar;22(2):306-312
pubmed: 27993444
J Bone Joint Surg Br. 2008 Jul;90(7):874-8
pubmed: 18591595
Clin Infect Dis. 2007 Nov 1;45(9):1113-9
pubmed: 17918072
Eur J Med Res. 2017 Mar 9;22(1):8
pubmed: 28274250
JB JS Open Access. 2018 Jul 12;3(3):e0060
pubmed: 30533595
J Am Acad Orthop Surg. 2010 Dec;18(12):771-2
pubmed: 21119143
Rev Med Suisse. 2010 Apr 7;6(243):731-4
pubmed: 20432995
J Clin Microbiol. 2008 Feb;46(2):824-5
pubmed: 18039794
N Engl J Med. 2004 Oct 14;351(16):1645-54
pubmed: 15483283
Enferm Infecc Microbiol Clin. 2017 Apr;35(4):236-242
pubmed: 27769681
J Arthroplasty. 2007 Sep;22(6 Suppl 2):90-3
pubmed: 17823024
J Arthroplasty. 2018 Feb;33(2):521-526
pubmed: 29033158
N Engl J Med. 2007 Aug 16;357(7):654-63
pubmed: 17699815
Clin Infect Dis. 2006 Jan 15;42(2):216-23
pubmed: 16355332
J Bone Joint Surg Am. 2012 Jul 18;94(14):e104
pubmed: 22810411
J Bone Jt Infect. 2017 Sep 28;2(4):175-183
pubmed: 29119076
FEMS Immunol Med Microbiol. 2011 Mar;61(2):133-40
pubmed: 21204998
J Clin Microbiol. 2013 Nov;51(11):3830-4
pubmed: 23946521
J Clin Microbiol. 2018 May 25;56(6):
pubmed: 29643202
J Clin Epidemiol. 1991;44(8):763-70
pubmed: 1941027
J Infect. 2012 Dec;65(6):541-8
pubmed: 22960370
N Engl J Med. 2004 Apr 1;350(14):1422-9
pubmed: 15070792
Surg Infect (Larchmt). 2017 Feb/Mar;18(2):164-169
pubmed: 27925502
Bioimpacts. 2011;1(3):183-7
pubmed: 23678425
J Arthroplasty. 2015 Sep;30(9 Suppl):39-41
pubmed: 26182982
Infect Control Hosp Epidemiol. 1992 Oct;13(10):606-8
pubmed: 1334988
Ann Lab Med. 2018 Nov;38(6):610-612
pubmed: 30027708
Clin Microbiol Infect. 2018 Jan;24(1):83.e1-83.e6
pubmed: 28559002
EFORT Open Rev. 2019 Jul 29;4(7):482-494
pubmed: 31423332
PLoS One. 2018 Apr 27;13(4):e0196418
pubmed: 29702663
Clin Orthop Relat Res. 2011 Nov;469(11):3049-54
pubmed: 21866421
Swiss Med Wkly. 2005 Apr 30;135(17-18):243-51
pubmed: 15965826
New Microbiol. 2008 Jan;31(1):97-104
pubmed: 18437847
Int Orthop. 2009 Jun;33(3):829-33
pubmed: 18327582
EFORT Open Rev. 2019 Oct 7;4(10):585-594
pubmed: 31754464
Diagn Microbiol Infect Dis. 2018 Feb;90(2):115-119
pubmed: 29191466
Bone Joint J. 2013 Nov;95-B(11):1450-2
pubmed: 24151261
Int Orthop. 2019 Aug;43(8):1891-1898
pubmed: 30191275
Infection. 2015 Oct;43(5):551-60
pubmed: 26021312
J Microbiol Methods. 2016 Feb;121:27-32
pubmed: 26689142
J Bone Joint Surg Am. 2013 Apr 3;95(7):644-51
pubmed: 23553300
Clin Orthop Relat Res. 2011 Nov;469(11):2992-4
pubmed: 21938532
J Clin Pathol. 2006 Jun;59(6):591-7
pubmed: 16731601

Auteurs

Christian Suren (C)

Klinik und Poliklinik für Orthopädie und Sportorthopädie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675, Munich, Germany. christian.suren@mri.tum.de.

Susanne Feihl (S)

Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, Technische Universität München, Trogerstr. 30, 81675, Munich, Germany.

Sabrina Cabric (S)

Centrum für Muskuloskeletale Chirurgie (CMSC), Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Ingo J Banke (IJ)

Klinik und Poliklinik für Orthopädie und Sportorthopädie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675, Munich, Germany.

Bernhard Haller (B)

Institut für medizinische Informatik, Statistik und Epidemiologie, Technische Universität München, Grillparzerstr. 18, 81675, Munich, Germany.

Andrej Trampuz (A)

Centrum für Muskuloskeletale Chirurgie (CMSC), Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Rüdiger von Eisenhart-Rothe (R)

Klinik und Poliklinik für Orthopädie und Sportorthopädie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675, Munich, Germany.

Peter M Prodinger (PM)

Klinik und Poliklinik für Orthopädie und Sportorthopädie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH